TNF inhibitors don't appear to increase malignancy risk in juvenile arthritis patients
Tumor necrosis factor inhibitors, a group of biologic drugs used to treat children with juvenile idiopathic arthritis, are not associated with a significantly increased risk of cancer, according to new research findings presented ...
Nov 13, 2016
0
0